Evidence map›Paper›PMID 24366250›Full record

ArticleInfection and immunity2014

Novel role for the yceGH tellurite resistance genes in the pathogenesis of Bacillus anthracis.

Sarah E Franks, Celia Ebrahimi, Andrew Hollands, Cheryl Y Okumura, Raffi V Aroian, Victor Nizet, Shauna M McGillivray

Open access · bronzeAbstract read
In one paragraph

Article in Infection and immunity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Genomic and metabolic characterization ofApplied and environmental microbiology · 2025
    Article
  4. Article
  5. Article
  6. Interactions between the Re-Emerging PathogenInternational journal of molecular sciences · 2022
    Review
  7. Emergence of K1 ST23 and K2 ST65 hypervirulentFrontiers in cellular and infection microbiology · 2022
    Article
  8. Identification of hypervirulentFrontiers in public health · 2022
    Article
  9. Article
  10. Frontiers in cellular and infection microbiology · 2019
    Article
  11. Article
  12. Comparative Genomics ofFrontiers in microbiology · 2017
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sarah E FranksDepartment of Biology, Texas Christian University, Fort Worth, Texas, USA.
Celia Ebrahimi
Andrew Hollands
Cheryl Y Okumura
Raffi V Aroian
Victor Nizet
Shauna M McGillivray
University of California, San Diego · USTexas Christian University · US

Funding

UCSD/SDSU IRACDAK12GM068524 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TREJO, JOANN · 2003 to 2025
$24.4M
Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Boosting Innate Immunity Through HIF to Treat Antibiotic-Resistant InfectionsR01AI093451 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOHNSON, RANDALL SCOTT, NIZET, VICTOR · 2011 to 2015
$4.9M
Cathelicidin in Skin ImmunityR37AI052453 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Richard L Gallo, Victor Nizet · 2019 to 2026
$4.6M
p38-mediated defense pathway against pore-forming toxinsR01GM071603 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AROIAN, RAFFI V · 2006 to 2014
$2.5M
Boosting Innate Immunity Through HIF to Treat Drug-Resistant Bacterial InfectionsR56AI090863 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI JOHNSON, RANDALL SCOTT, NIZET, VICTOR · 2010 to 2010
$704k
C. elegans model of B. anthracis immunity & pathogenesisR21AI065993 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI AROIAN, RAFFI V · 2006 to 2007
$419k
NIAID NIH HHS AI065993NIAID NIH HHS R01 AI052453NIAID NIH HHS R01 AI093451NIAID NIH HHS R21 AI065993NIAID NIH HHS R37 AI052453NIAID NIH HHS R56 AI090863NIGMS NIH HHS GM068524NIGMS NIH HHS K12 GM068524NIGMS NIH HHS R01 GM071603
6 · The paper itself

Abstract

Bacillus anthracis, the causative agent of anthrax, relies on multiple virulence factors to subvert the host immune defense. Using Caenorhabditis elegans as an infection model, we screened approximately 5,000 transposon mutants of B. anthracis Sterne for decreased virulence. One of the attenuated mutants resulted in loss of expression of yceG and yceH, the last two genes in a six-gene cluster of tellurite resistance genes. We generated an analogous insertional mutant to confirm the phenotype and characterize the role of yceGH in resistance to host defenses. Loss of yceGH rendered the mutants more sensitive to tellurite toxicity as well as to host defenses such as reactive oxygen species and the cathelicidin family of antimicrobial peptides. Additionally, we see decreased survival in mammalian models of infection, including human whole blood and in mice. We identify a novel role for the yceGH genes in B. anthracis Sterne virulence and suggest that C. elegans is a useful infection model to study anthrax pathogenesis.

Indexed as

AnimalsAnthraxBacillus anthracisBacterial ProteinsCaenorhabditis elegansImmunity, InnateMutationTelluriumVirulenceVirulence FactorsBacterial ProteinsTelluriumtellurous acidVirulence Factors

Identifiers

PMID24366250
PMCPMC3957989
OpenAlexW2160647174

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.